Last reviewed · How we verify

NCT05811806

Physiological Changes From Hand Movement Training

Completed NA Last updated 13 April 2023
What this trial tests

NA trial testing Treatment using the MyHand System in Stroke in 11 participants. Completed in 4 August 2022.

Timeline
2 May 2022
Primary endpoint
4 August 2022
4 August 2022

Quick facts

Lead sponsorIRegained Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment11
Start date2 May 2022
Primary completion4 August 2022
Estimated completion4 August 2022
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

IRegained Inc.

Who can join

Adults 18 to 100, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

11 participants with upper-limb impairment will be recruited from community sources. They will be invited to participate in a 15-day trial involving the IRegained device. The study will involve 2 assessment visits to Baycrest, before and after the treatment, and 15 treatment visits. The data from the pilot study will be analyzed both quantitatively and qualitatively, as outcomes and explicit feedback from participants will be used to further optimize the device for future studies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Treatment using the MyHand System

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other IRegained Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05811806.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing